Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Titan Medical Reports Financial Results for the First Quarter 2024
-
Verrica Pharmaceuticals Reports First Quarter 2024 Financial Results
-
HydroGraph to Host Investor Webinar, Attend Upcoming Conferences
-
Avalo Reports First Quarter 2024 Financial Results and Provides Business Updates
-
Auction result of Treasury Bills - RIKV 24 0717 - RIKV 24 1120
-
Dassault Systèmes: declaration of the number of outstanding shares and voting rights as of April 30, 2024
-
Encore Capital Group, Inc. Announces Proposed Senior Secured Notes Offering
-
Milestone Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Regulatory and Corporate Update
-
Gildan Activewear Publishes Investor Presentation for 2024 Annual Meeting
-
Draganfly to Host Shareholder Update and Q1 Earnings Call
-
Aurora Spine Corporation Schedules Conference Call to Update Investors and Discuss First Quarter Fiscal Year 2024 Financial Results
-
EnviroGold Global Announces the Appointment of Paul McRae as an Independent Director
-
The Joint Corp. Engages Capstone Partners to Accelerate Refranchising Efforts
-
Boussard & Gavaudan Investment Management LLP: Form 8.3 - Network International Holdings PLC
-
Aya Gold & Silver Extends Main Zone to 5km and Adds 7 New Permits at Boumadine
-
Carbon Streaming Forms Independent Committee
-
Falco Announces the Opening of Espace Falco and Invites the Population to the Public Information Meeting Organized by the BAPE on the Falco Horne 5 Project
-
Mirasol Identifies New Porphyry Targets at the El Potro Prospect and also Extends the VN-Zone by more than 3 km at the Sobek Copper-Gold Project in Vicuña District, Chile
-
Evergold – CSAMT Survey Over DEM1 Prospect, B.C., Reveals Large Target Extending Across All Lines and to Depth Below Reconnaissance Drill Holes
-
The Keg Royalties Income Fund announces May 2024 cash distribution
-
Abacus Life Reports First Quarter 2024 Results
-
Entera Bio to Present Phase 1 Data from First-in-Class, PTH(1-34) Peptide Tablets (EB612) for the Treatment of Hypoparathyroidism at ENDO 2024
-
Lantronix Inc. Appoints Mathi Gurusamy as Chief Strategy Officer to Drive Strategic Growth and Build Market Leadership
-
Apogee Therapeutics Highlights Pipeline Progress and Reports First Quarter 2024 Financial Results
-
Medicenna Provides Update on its Presentations at the 2024 ASCO Annual Meeting
-
CECO Environmental Announces Upcoming Investor Conferences
-
Talisker Signs Ore Hauling Agreement for Bralorne Gold Project
-
Walden Biosciences Announces Research Collaboration with World Renowned Genetic Epidemiologist to Advance Work on Causal Role of suPAR in Chronic Kidney Disease
-
Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2024 Financial Results
-
New Jersey awards NFI subsidiary New Flyer a contract for up to 1,300 Xcelsior® Transit Buses
-
ORLADEYO® (berotralstat) Approved in Mexico
-
Lycia Therapeutics Completes $106.6 Million Series C Financing to Advance Pipeline of LYTAC Extracellular Protein Degraders to the Clinic
-
Bitfarms Announces Acceleration of Previously Announced Termination of CEO and Provides Update on New CEO Appointment
-
Bitfarms Reschedules First Quarter Conference Call to May 15th at 8:00am ET
-
LOBO EV Launches New E-Moped Models at China Cycle Exhibition
-
Tiziana Life Sciences Files for Orphan Drug Designation for Intranasal Foralumab
-
Lilium in advanced discussions with French government to expand industrial footprint with high-volume facilities in France
-
Autolus Therapeutics Announces Delay to its First Quarter 2024 Earnings Release and Conference Call
-
GXO Receives 2023 Whirlpool Supply Chain Supplier Awards
-
Cibus to Participate in the BMO Global Farm to Market Conference
-
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for First Quarter 2024
-
Ovid Therapeutics to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference
-
Village Farms International Appoints Finance and Operations Veteran Carolyn Hauger to Board
-
TScan Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
-
Galera Reports First Quarter 2024 Financial Results and Recent Corporate Updates
-
Tourmaline Bio Reports First Quarter 2024 Financial Results and Recent Business Highlights
-
CECO Environmental Announces Upcoming Investor Conferences
-
OTC Markets Group Welcomes BioLargo, Inc. to OTCQX
-
Iterum Therapeutics Reports First Quarter 2024 Financial Results
-
Signify share repurchase periodic update


